Monash University Investigators One Step Closer to Novel Treatment for MS

Monash University Investigators One Step Closer to Novel Treatment for MS

Monash University investigators are in pursuit for a new treatment for multiple sclerosis (MS) that they believe may actually reverse effects of the disease on the brain. They are exploring the use of an experimental drug called Dipta. During preclinical research on mice, they found that paralyzed mice were able to actually walk again.

Now, according to several Australian news sources including 7NEWS, the Melbourne-based team, led by Dr. Steve Petratos, needs to secure $2 million for clinical trials. After all, the stakes are big. There is no cure for MS. Nearly 1 million people are afflicted with MS in the United States and about 25,600 in Australia. 

Dr Steven Petratos told 7NEWS, “We don’t have any drugs that are available at the moment that can enhance the repair mechanisms that this drug is purported to do.”

The Background

Dr. Petratos and team have generated strong data indicating that a protein called MCT8 is vital for the survival of oligodendrocytes, the cells that are responsible for the creation of myelin. They have also developed a drug called DIPTA, which can mimic the activity of the MCT8 protein. Their work to date suggests that it may be possible to use...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee